Loading...

RBC Lysis Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Red blood cell lysis buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420301 100 mL £45
Check Availability


Need larger quantities of this item?
Request Bulk Quote
420302 500 mL £141
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Red Blood Cell (RBC) Lysis Buffer has been designed, formulated, and tested to ensure optimal lysis of RBCs in single cell suspensions with minimal effects on leukocytes. RBC Lysis Buffer is supplied as a 10X solution containing ammonium chloride, potassium carbonate, and EDTA, and should be diluted in deionized water prior to use. Nucleated RBCs are not effectively lysed with ammonium chloride. Test

Product Details
Technical Data Sheet (pdf)

Product Details

Formulation
This red blood cell (RBC) lysis buffer is supplied as a 10X solution and should be diluted to 1X in deionized water. 100 ml of 10X concentrate will yield a quantity of 1X solution that is sufficient to lyse 500 samples.
Preparation
The pH of the 1X solution should fall within the range of pH 7.1-7.4. Adjust the pH if necessary. Warm the 1X solution to room temperature prior to use.
Storage & Handling
Store RBC lysis buffer between 2°C and 8°C.
Application Notes

A. Lysis of Mouse Spleen RBCs:
1. Harvest mouse spleen and prepare a single cell suspension.
2. Pellet the cells by centrifugation (350 x g); aspirate the supernatant.
3. Dilute the 10X Red Blood Cell Lysis Buffer to 1X working concentration with deionized water and resuspend the pellet in 5 ml of 1X Lysis Buffer.
4. Incubate on ice for 4-5 minutes with occasional shaking.
5. Stop the reaction by diluting the Lysis Buffer with 20-30 ml of 1X PBS.
6. Spin the cells (350 x g) and discard the supernatant.
7. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer Cat. No. 420201), wash 1X.
8. Count cells, adjust density, and proceed with cell staining procedures.
B. Lysis of Human Peripheral Blood RBCs:
1. Dilute the 10X RBC Lysis Buffer to 1X working concentration with deionized water. Warm the 1X solution to room temperature prior to use.
2. Add 2.0 ml of 1X RBC Lysis Buffer to each tube containing up to 100 µl of whole blood.
3. Gently vortex each tube immediately after adding the lysing solution. Incubate at room temperature, protected from light, for 10-15 minutes.
4. Centrifuge 350 x g for 5 minutes. Aspirate supernatant without disturbing pellet.
5. Resuspend the pellet in the appropriate buffer (e.g., BioLegend Cell Staining Buffer, Cat. No. 420201), wash 1X.
6. Resuspend and proceed with further procedures.

Application References

(PubMed link indicates BioLegend citation)
  1. Adams RA, et al. 2007. J. Exp. Med. 204:571.
  2. Feild-Corbett C, et al. 2009. Stem Cells. PubMed
  3. de Resende MM, et al. 2010. Physiol Genomics. 42:437. PubMed
  4. Roybal JD, et al. 2011. Mol Cancer Res. 9:25. PubMed
  5. Boldin MP, et al. 2011. J Exp Med. PubMed
  6. Kahlenberg JM, et al. 2011. J. Immunol. 187:6143. PubMed
  7. Deiuliis JA, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:399. PubMed
  8. Wu CY, et al. 2012. PLoS One. 7:e42365. PubMed
  9. Hsia BJ, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  10. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  11. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. PubMed
  12. Saraiva AM, 2013. Hum Immunol. 74:207. PubMed
  13. Koon HW, et al. 2013. J Vis exp. 68:4208. PubMed
  14. Ma Dy, et al. 2013. J Virol. 87:3361. PubMed
  15. Han W, 2013. J. Immunol. 190:4786. PubMed
  16. Garcia-Acros I, et al. 2013. J Biol Chem. 288:14046. PubMed
  17. Zhao JL, et al. 2013. Elife. 21:537. PubMed
  18. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. PubMed
  19. Yamasaki S, et al. 2013. Clin Vaccine immunol. 20:1508. PubMed
  20. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  21. Liu X, et al. 2013. Invest Ophthalmol Vis Sci. 54:7386. PubMed
  22. Fullerton AM, et al. 2013. Toxicol Sci. 136:72. PubMed
  23. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  24. Varga T, et al. 2013. J. Immunol. 191:5695. PubMed
  25. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  26. Chang YJ, et al. 2014. Cytotherapy. 16:560. PubMed
  27. Kim MJ, et al. 2014. Mol Pharmacol. 86:284. PubMed
  28. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  29. Szulzewsky F, et al. 2015. PloS One. 10:116644. PubMed
Product Citations
  1. Nguyen, H. P., An, K., et al. 2025. Nat Biotechnol. 43(12),1979-1995. PubMed
  2. Jebbawi, F., Olomski, F., et al. 2025. Allergy. 80(12),3377-3390. PubMed
  3. Xu, L., Paine, A. C., et al. 2025. J Virol. 99(10),e0126125. PubMed
  4. Haykal, T., Yang, R., et al. 2025. Cancer Res. 85(24),4995-5014. PubMed
  5. Li, S., Wang, Y., et al. 2025. Signal Transduct Target Ther. 10(1),323. PubMed
  6. Huang, H., Li, S., et al. 2025. Sci Rep. 15(1),35547. PubMed
  7. Li, Q., de Oliveira Formiga, R., et al. 2025. Nat Metab. 7(12),2510-2530. PubMed
  8. Phoon, Y. P., Wolfarth, A. A., et al. 2025. Sci Rep. 15(1),37950. PubMed
  9. Choi, Y., Shim, M., et al. 2025. Exp Mol Med. 57(11),2487-2504. PubMed
  10. Chen, Y., Liao, Y., et al. 2025. Nat Commun. 16(1),10249. PubMed
  11. Han, C., Yuan, H., et al. 2025. FASEB J. 39(23),e71273. PubMed
  12. Wessel, B. M., Castro, J. N., et al. 2025. Organoids. 4(4),0. PubMed
  13. Qiu, Z., Song, N. J., et al. 2025. J Clin Invest. 0(0),0. PubMed
  14. Lu, W., Jin, T., et al. 2025. Sci Rep. 15(1),44077. PubMed
  15. Izgutdina, A., Rashid, T., et al. 2025. J Immunother Cancer. 13(12),0. PubMed
  16. Dobie R, et al. 2020. Cell Reports. 29(7):1832-1847.e8.. PubMed
  17. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  18. Deiuliis J, et al. 2012. Am J Physiol Lung Cell Mol Physiol. 302:L399. PubMed
  19. Jin J, et al. 2012. Arterioscler Thromb Vasc Biol. 32:2901. . PubMed
  20. Barros-Martins J, et al. 2016. J Immunol. 196: 3642 - 3652. PubMed
  21. Zhou B, et al. 2020. Nat Immunol. 1.868055556. PubMed
  22. Tan J, et al. 2021. iScience. 24(8):102835. PubMed
  23. Asem M, et al. 2020. Cancer Res. 1156:80. PubMed
  24. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
  25. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  26. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  27. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  28. Rathakrishnan A, et al. 2020. Viruses. 12: . PubMed
  29. Wang Y, et al. 2021. Cancer Res. 81:384. PubMed
  30. Wang H, et al. 2022. Nat Biomed Eng. 6:882. PubMed
  31. Yeh PY, et al. 2022. Sens Actuators B Chem. 353: . PubMed
  32. Ammothumkandy A, et al. 2022. Nat Neurosci. 25:493. PubMed
  33. Melendez E, et al. 2022. Development. 149: . PubMed
  34. Argueta LB, et al. 2022. iScience. 25:104223. PubMed
  35. Wang S, et al. 2022. Adv Sci (Weinh). 9:e2201258. PubMed
  36. Meena AS, et al. 2022. Cell Rep. 39:110937. PubMed
  37. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  38. Sugimoto S, et al. 2022. Nat Metab. 4:775. PubMed
  39. Moore AR, et al. 2022. Cell Rep. 41:111651. PubMed
  40. Isildar B, et al. 2022. Inflamm Regen. 42:55. PubMed
  41. Xu Q, et al. 2022. Front Med (Lausanne). 9:940554. PubMed
  42. Alexandrou AT, et al. 2022. iScience. 25:105546. PubMed
  43. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  44. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  45. Tratwal J, et al. 2022. Front Endocrinol (Lausanne). 13:1001210. PubMed
  46. Xie Z, et al. 2022. Cell Discov. 8:133. PubMed
  47. Xiang X, et al. 2022. Medicine (Baltimore). 101:e32558. PubMed
  48. Yu Z, et al. 2023. Cancer Res. 83:700. PubMed
  49. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  50. Oh S, et al. 2023. Nat Biotechnol. :. PubMed
  51. Marritt KL, et al. 2023. Front Immunol. 13:1087991. PubMed
  52. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  53. Vyas M, et al. 2023. Front Immunol. 13:1098445. PubMed
  54. Li XF, et al. 2023. J Exp Med. 220: . PubMed
  55. Wang J, et al. 2023. Inflamm Regen. 43:12. PubMed
  56. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  57. Feng J, et al. 2022. Immunity. 55:405. PubMed
  58. Rustagi Y, et al. 2022. Diabetes. 71:1149. PubMed
  59. Guennoun R, et al. 2022. Cancers (Basel). 14:. PubMed
  60. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  61. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  62. Wakiyama H, et al. 2022. Cancer Immunol Res. 10:1386. PubMed
  63. Roweth HG, et al. 2022. Sci Adv. 8:eabo5224. PubMed
  64. Zhong J, et al. 2022. J Adv Res. 41:145. PubMed
  65. Yun HJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  66. Daum P, et al. 2023. Front Immunol. 13:991347. PubMed
  67. Rao D, et al. 2023. Eur J Immunol. 53:e2250258. PubMed
  68. Le DT, et al. 2023. iScience. 26:106059. PubMed
  69. Romo-Rodríguez R, et al. 2023. Arch Med Res. 54:197. PubMed
  70. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  71. MacPherson KP, et al. 2023. Front Cell Neurosci. 17:895017. PubMed
  72. Chen Z, et al. 2023. Nat Commun. 14:1839. PubMed
  73. Martins Nascentes Melo L, et al. 2023. J Immunother Cancer. 11:. PubMed
  74. Ramalingam P, et al. 2023. Nat Commun. 14:2018. PubMed
  75. Choi YJ, et al. 2023. Nat Commun. 14:2045. PubMed
  76. He Q, et al. 2023. Parasit Vectors. 16:139. PubMed
  77. Pattnaik A, et al. 2023. Vaccines (Basel). 11:. PubMed
  78. Mulcrone PL, et al. 2023. Sci Rep. 13:8436. PubMed
  79. Villalba N, et al. 2023. J Neuroinflammation. 20:127. PubMed
  80. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  81. Matsudaira T, et al. 2023. Commun Biol. 6:665. PubMed
  82. Sandovici I, et al. 2022. Dev Cell. 57:63. PubMed
  83. Spengler J, et al. 2016. J Infect Dis. 214: S308 - S318. PubMed
  84. Zheng M, et al. 2016. J Immunol. 196: 4122 - 4131. PubMed
  85. St-Pierre S, et al. 2016. PLoS One. 11: 0150230. PubMed
  86. Ensan S, et al. 2015. Nat Immunol. 17: 159-168. PubMed
  87. Jaiswal M, et al. 2015. Sci Rep. 5: 15221. PubMed
  88. Hou J, et al. 2015. J Mol Cell Biol. 7: 338-350. PubMed
  89. Fujii H, et al. 2015. PLoS One. 10: 0133216. PubMed
  90. Herisson F, et al. 2018. Nat Neurosci. 21:1209. PubMed
  91. Pracht K, et al. 2021. Eur J Immunol. 51:1089. PubMed
  92. Radwanska M, et al. 2020. Methods Mol Biol. 2116:721. PubMed
  93. Rendon CJ, et al. 2022. Front Endocrinol (Lausanne). 13:995499. PubMed
  94. Effern M, et al. 2022. STAR Protoc. 3:101038. PubMed
  95. Della Verde G, et al. 2022. Life Sci Alliance. 5:. PubMed
  96. Su C, et al. 2021. Front Oncol. 11:719564. PubMed
  97. Jacoby E, et al. 2021. NPJ Regen Med. 6:58. PubMed
  98. Chen Z, et al. 2020. Glia. 68:2148. PubMed
  99. Seow JJW, et al. 2021. Front Med (Lausanne). 8:603374. PubMed
  100. Shin J, et al. 2020. Hum Gene Ther. . PubMed
  101. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  102. Liu W, et al. 2017. Int J Environ Res Public Health. 10.3390/ijerph14060592. PubMed
  103. Pietrocola F, et al. 2017. Autophagy. 0.935416667. PubMed
  104. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  105. Wang J, et al. 2020. Sci Rep. 10:12785. PubMed
  106. Ma Y, et al. 2014. Cancer Res. 74:436. PubMed
  107. Magalhães L, et al. 2015. PLoS Negl Trop Dis. 10: 0003816. PubMed
  108. Moraes-Vieira P, et al. 2016. Diabetes. 65: 1317 - 1327. PubMed
  109. Garcia-Fabiani MB, et al. 2020. STAR Protoc. :1. PubMed
  110. Zhang J, et al. 2021. Aging (Albany NY). 13:17880. PubMed
  111. Press AT, et al. 2021. EMBO Mol Med. 13:e14436. PubMed
  112. Sima LE, et al. 2021. J Immunother Cancer. 9:. PubMed
  113. Ma H, et al. 2021. Front Immunol. 12:760095. PubMed
  114. McGill CJ, et al. 2021. STAR Protoc. 2:100948. PubMed
  115. Lutze J, et al. 2022. Methods Mol Biol. 2394:299. PubMed
  116. Hosseini A, et al. 2022. Evid Based Complement Alternat Med. 2022:5639226. PubMed
  117. Bikorimana JP, et al. 2022. Cell Rep Med. 3:100534. PubMed
  118. Zhang L, et al. 2022. JCI Insight. 7:. PubMed
  119. Baldominos P, et al. 2022. STAR Protoc. 3:101795. PubMed
  120. Pridans C, et al. 2016. J Immunol. 197: 2297 - 2305. PubMed
  121. Mircheff A, et al. 2016. Ocul Surf. 14:460-483. PubMed
  122. Pennington L, et al. 2016. Nat Commun. 7:11610. PubMed
  123. Koon H, et al. 2012. J Vis Exp. 68: 4208. PubMed
  124. Boldin M, et al. 2011. J Exp Med. 208:1189. PubMed
  125. Sun CC, et al. 2020. Genome Med. 0.553472222. PubMed
  126. Bravo–San Pedro JM, et al. 2019. Cell Metab. 30:754. PubMed
  127. Clark EL, et al. 2017. PLoS Genet. 13:e1006997. PubMed
  128. Cantor JR, et al. 2017. Cell. 169:258. PubMed
  129. Ji WJ, et al. 2017. Cytometry B Clin Cytom. 92:371. PubMed
  130. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
  131. Wu Y, et al. 2021. Nat Biomed Eng. 5:1336. PubMed
  132. Meng S, et al. 2022. Exp Anim. . PubMed
  133. Kokkinopoulos I, et al. 2021. Sci Rep. 11:15759. PubMed
  134. Johnson CL, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H756. PubMed
  135. Stringhini M, et al. 2021. MAbs. 13:1868066. PubMed
  136. Devalaraja S, et al. 2020. Cell. 1098:180. PubMed
  137. Elisabeth Schrumpf, Xiaojun Jiang 2017. Physiol Rep. 10.14814/phy2.13117. PubMed
  138. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  139. Brunmeir R, et al. 2016. PLoS Genet. 12:e1006474. PubMed
  140. Sakamoto S, et al. 2020. OncoImmunology. 8(12):e1671760.. PubMed
  141. Rico C, et al. 2012. Carcinogenesis. 33:2283. PubMed
  142. Hamour S, et al. 2015. PLoS One. 10: 0136238. PubMed
  143. Bazett M, Haston M 2016. Sci Rep. 6:19189. PubMed
  144. Luo B, et al. 2016. J Neurosci. 36: 9590 - 9603. PubMed
  145. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  146. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  147. Zhai Z, et al. 2021. Medicine (Baltimore). 100:e26214. PubMed
  148. Hu D, et al. 2021. J Cell Mol Med. 25:2900. PubMed
  149. Jones N, et al. 2021. Nat Commun. 12:1209. PubMed
  150. Wang D, et al. 2021. Signal Transduct Target Ther. 6:376. PubMed
  151. Machado H, et al. 2021. PLoS Pathog. 17:e1009933. PubMed
  152. Yan X, et al. 2022. Int J Biol Sci. 18:585. PubMed
  153. Singh SS, et al. 2021. Eur J Med Chem. 216:113312. PubMed
  154. Pokhrel RH, et al. 2022. Int J Mol Sci. 23:. PubMed
  155. Facchini M, et al. 2014. J Vis Exp. 85: 51019. PubMed
  156. Ilievski V, et al. 2015. PLoS One. 10: 0136502. PubMed
  157. Saraiva A, et al. 2013. Hum Immunol. 74:207. PubMed
  158. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  159. Jiang J, et al. 2018. Cancer Med. 3.504861111. PubMed
  160. Chen Z, et al. 2017. Cancer Res. 77:2266. PubMed
  161. Kim M, et al. 2017. Int J Mol Sci. 10.3390/ijms18061275. PubMed
  162. Mo L, et al. 2022. Front Oncol. 12:871489. PubMed
  163. Huang L, et al. 2021. J Cell Physiol. 236:7308. PubMed
  164. Whytock KL, et al. 2022. iScience. 25:104772. PubMed
  165. Neufeld L, et al. 2021. Sci Adv. 7:. PubMed
  166. Friedman G, et al. 2020. Nat Cancer. 1:692. PubMed
  167. Kumar A, et al. 2021. Part Fibre Toxicol. 18:43. PubMed
  168. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  169. Scherer SD, et al. 2021. Breast Cancer Res. 23:100. PubMed
  170. Jeong J, et al. 2021. Immune Netw. 21:e31. PubMed
  171. Sitaraman S, et al. 2021. JCI Insight. 6:. PubMed
  172. Orr AN, et al. 2021. Int J Mol Sci. 22:. PubMed
  173. Wang K, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.016. PubMed
  174. Appelbe O, et al. 2017. J Control Release.. 10.1016/j.jconrel.2017.09.043. PubMed
  175. Tang J, et al. 2017. Proc Natl Acad Sci U S A. 114:E7441. PubMed
  176. Liccardi G, et al. 2019. Mol Cell. 73:413. PubMed
  177. Patil R, et al. 2019. J Biomed Opt. 24:1. PubMed
  178. Ongaro T, et al. 2020. Oncotarget. 3.026388889. PubMed
  179. Kahlenberg J, et al. 2011. J Immunol. 187:6143. PubMed
  180. Han W, et al. 2013. J Immunol. 190:4786. PubMed
  181. Yamasaki S, et al. 2013. Clin Vaccine Immunol. 20:1508. PubMed
  182. Fukui R, et al. 2016. J Immunol. 196: 416 - 427. PubMed
  183. Rodriguez-Garcia M, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.72. PubMed
  184. Kildisiute G, et al. 2021. Sci Adv. 7: . PubMed
  185. Schiferle EB, et al. 2021. Sci Adv. 7: . PubMed
  186. Devalaraja S, et al. 2020. STAR Protoc. 1:100188. PubMed
  187. Bigenwald C, et al. 2021. Nat Med. 27:851. PubMed
  188. Gingrich AA, et al. 2021. Front Immunol. 12:670309. PubMed
  189. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  190. Deng J, et al. 2021. Breast Cancer Res Treat. 185:85. PubMed
  191. Vivanco Gonzalez N, et al. 2022. STAR Protoc. 3:101280. PubMed
  192. Qin L, et al. 2022. Nat Commun. 13:6051. PubMed
  193. Escudero-Lara A, et al. 2022. Front Behav Neurosci. 16:946975. PubMed
  194. Agrawal V, et al. 2016. J Leukoc Biol. 100: 261 - 274. PubMed
  195. Martínez-Muriana A, et al. 2020. Stem Cell Res Ther. 11:53. PubMed
  196. Pennig J, et al. 2019. Sci Rep. 9:17937. PubMed
  197. Wang B, et al. 2017. Stem Cell Res Ther.. 10.1186/s13287-017-0744-6. PubMed
  198. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  199. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  200. Evans AK, et al. 2020. Neurobiol Dis. 146:105089. PubMed
  201. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  202. Choi JW, et al. 2020. PLoS One. 15:e0235518. PubMed
  203. Alban TJ, et al. 2020. Front Immunol. 1.285416667. PubMed
  204. Jiang S, et al. 2017. Toxicology Lett. 10.1016/j.toxlet.2017.03.015. PubMed
  205. Elphinstone R, et al. 2017. Infect Immun. 10.1128/IAI.00371-17. PubMed
  206. Kernfeld EM, et al. 2018. Immunity. 48:1258. PubMed
  207. Nwani NG, et al. 2019. Cancers (Basel). 0.806944444. PubMed
  208. Ramalingam P, et al. 2020. Nat Commun. 11:666. PubMed
  209. Garcia-Arcos I, et al. 2013. J Biol Chem. 288:14046. PubMed
  210. Sci T 2013. Toxicol Sci. 136:72. PubMed
  211. Metz H, et al. 2016. Proc Natl Acad Sci U S A. 113: 8795 - 8800. PubMed
  212. Cheng Q, et al. 2020. Nat Nanotechnol. 0.842361111. PubMed
  213. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  214. Alghamri MS, et al. 2020. Methods Enzymol. 632:215. PubMed
  215. Yu Z, et al. 2021. Front Oncol. 11:659251. PubMed
  216. Deng J, et al. 2021. Nat Cancer. 2:503. PubMed
  217. Beaudoin-Bussières G, et al. 2022. Cell Rep. 38:110368. PubMed
  218. Hu H, et al. 2021. Cancer Immunol Res. 9:1298. PubMed
  219. Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed
  220. So EY, et al. 2021. Am J Physiol Cell Physiol. 321:C569. PubMed
  221. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  222. Lizotte P, et al. 2016. Sci Rep. 6:31745. PubMed
  223. Mirando AC, et al. 2020. Oncoimmunology. 9:1760685. PubMed
  224. Rosenbluth JM, et al. 2020. Nat Commun. 11:1711. PubMed
  225. Tavakol DN, et al. 2021. Curr Protoc. 1:e275. PubMed
  226. Ullah I, et al. 2021. Immunity. 54:2143. PubMed
  227. He Y, et al. 2021. Front Immunol. 12:641206. PubMed
  228. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  229. Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed
  230. Meng YM, et al. 2021. Nat Commun. 12:6011. PubMed
  231. Zhu QY, et al. 2021. Nat Commun. 12:6624. PubMed
  232. Patel M, et al. 2021. Cancer Res. 81:3985. PubMed
  233. Shi X, et al. 2021. Nat Commun. 12:2547. PubMed
  234. Ramaswamy G, et al. 2017. Sci Rep. 10.1038/srep45140. PubMed
  235. Wen J, et al. 2017. J Hematol Oncol. 10.1186/s13045-017-0489-9. PubMed
  236. Ahmad S,et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. . 10.1016/j.pnpbp.2017.10.001. PubMed
  237. Hang J, et al. 2019. Cancer Med. 1.254166667. PubMed
  238. Tan X, et al. 2019. Sci Rep. 2.7125. PubMed
  239. Lienemann PS, et al. 2020. Adv Sci (Weinh). 7:1903395. PubMed
  240. Zhao J, et al. 2013. Elife. 21:537. PubMed
  241. Weber G, et al. 2015. Surgery. 158: 248-254. PubMed
  242. Jiang H, et al. 2016. Nat Med. 10.1038/nm.4123. PubMed
  243. Elgueta R, et al. 2016. J Immunol. 197: 3970 - 3981. PubMed
  244. Sharma A, et al. 2020. Cell. 183(2):377-394.e21. PubMed
  245. Hills LB, et al. 2021. J Immunol. 206:89. PubMed
  246. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  247. Pace J, et al. 2022. J Biomed Opt. 27:. PubMed
  248. Pedicona F, et al. 2022. Sci Signal. 15:eabl7989. PubMed
  249. Fidalgo MF, et al. 2022. Life Sci Alliance. 5:. PubMed
  250. Stirling ER, et al. 2022. J Immunother Cancer. 10:. PubMed
  251. Theurl I, et al. 2016. Nat Med. 10.1038/nm.4146. PubMed
  252. Schweppe RE, et al. 2019. Mol Cancer Res. 17:1036. PubMed
  253. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  254. Yang A, et al. 2018. Cancer Discov. 0.525. PubMed
  255. Rentsendorj A, et al. 2017. Brain Behav Immun. 10.1016/j.bbi.2017.08.019. PubMed
  256. Yan Q, et al. 2022. Clin Transl Med. 12:e1084. PubMed
  257. Zhai K, et al. 2021. Nat Cancer. 2:1136. PubMed
  258. Zhao D, et al. 2020. Cancer Discov. 10:1374. PubMed
  259. Castoldi F, et al. 2020. Cell Death Discov. 0.339583333. PubMed
  260. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  261. Morris C, et al. 2017. MBio. 10.1128/mBio.00036-17. PubMed
  262. Dyck S, et al. 2018. J Neuroinflammation. 0.6875. PubMed
  263. Yang YS, et al. 2020. Mol Ther Methods Clin Dev. 17:922. PubMed
  264. Gangwar RS, et al. 2020. Sci Rep. 10:14348. PubMed
  265. Varga T, et al. 2013. J Immunol. 191:5695. PubMed
  266. Samuelson D, et al. 2016. J Immunol. 196: 2655 - 2665. PubMed
  267. Tsao P, et al. 2016. Proc Natl Acad Sci U S A. 113: 8242 - 8247. PubMed
  268. Soncini M, et al. 2016. Proc Natl Acad Sci U S A. 113: E6219 - E6227. PubMed
  269. Yang C, et al. 2016. Sci Rep. 6:34643. PubMed
  270. Nowyhed H, et al. 2017. Sci Rep. 7:40273. PubMed
  271. De Domenico E, et al. 2020. STAR Protoc. 1:100233. PubMed
  272. Wang Z, et al. 2020. Cell Rep. 33:108472. PubMed
  273. Sadik A, et al. 2020. Cell. 1252:182. PubMed
  274. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  275. Ito T, et al. 2021. Nat Commun. 12:2232. PubMed
  276. Hollerbach A, et al. 2021. J Thromb Haemost. . PubMed
  277. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  278. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  279. Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed
  280. Majumdar D, et al. 2021. Curr Protoc. 1:e216. PubMed
  281. Michelotti TC, et al. 2022. Front Cell Dev Biol. 10:1025240. PubMed
  282. Ren X, et al. 2022. STAR Protoc. 3:101818. PubMed
  283. Sauter K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G533 - G547. PubMed
  284. Song C, et al. 2015. Blood. 126: 1813 - 1822. PubMed
  285. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  286. Gladow N, et al. 2020. PLoS One. 15:e0227734. PubMed
  287. Ramachandran P, et al. 2019. Nature. 575:512. PubMed
  288. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  289. Bowers J, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01221. PubMed
  290. Feng D, et al. 2022. Nat Commun. 13:5554. PubMed
  291. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  292. Xiang Y, et al. 2022. Skelet Muscle. 12:19. PubMed
  293. Yamazaki T, et al. 2021. Oncoimmunology. 10:1962592. PubMed
  294. Zhang J, et al. 2020. Pain. 161:1381. PubMed
  295. Heim CE, et al. 2020. Nature Microbiology. 5(10):1271-1284. PubMed
  296. Canali S, et al. 2017. Blood. 129(4):405-414. PubMed
  297. Shen X, et al. 2016. Sci Rep. 6:38778. PubMed
  298. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  299. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  300. Bichsel C, et al. 2017. Sci Rep. 10.1038/s41598-017-09928-1. PubMed
  301. James M, et al. 2017. J Nucl Med. . 10.2967/jnumed.117.189597. PubMed
  302. Annibaldi A, et al. 2018. Mol Cell. 69:566. PubMed
  303. Hill SJ, et al. 2018. Cancer Discov. 1.308333333. PubMed
  304. Ma D, et al. 2013. J Virol. 87:3361. PubMed
  305. Kraft P, et al. 2013. Stroke. 44:3202. PubMed
  306. Kim M, et al. 2014. Mol Pharmacol. 86:284. PubMed
  307. Cekic C, et al. 2014. Cancer Res. 74:7250. PubMed
  308. Pankova D, et al. 2016. Mol Cancer Res. 14: 287 - 295. PubMed
  309. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  310. Tulasi DY, et al. 2021. Cell Mol Gastroenterol Hepatol. 11:1437. PubMed
  311. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  312. Xue X, et al. 2021. Cent Eur J Immunol. 46:191. PubMed
  313. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  314. Yang YS, et al. 2022. Nat Commun. 13:6175. PubMed
  315. Muñoz-Ruiz M, et al. 2016. Nat Immunol. 10.1038/ni.3424. PubMed
  316. Chang Y, et al. 2014. Cytotherapy. 16:560. PubMed
  317. Hsia B, et al. 2012. J Allergy Clin Immunol. 130:205. PubMed
  318. Resende M, et al. 2010. Physiol Genomics. 42:437. PubMed
  319. McLaughlin S, et al. 2019. Nat Commun. 3.795833333. PubMed
  320. Koury J, et al. 2019. PLoS One. 14:e0218670. PubMed
  321. Zhang Z, et al. 2017. Journal of Translational Medicine. 10.1186/s12967-017-1196-6. PubMed
  322. Li N, et al. 2022. Nat Commun. 13:7281. PubMed
  323. Soileau AM, et al. 2022. Vet Sci. 9:. PubMed
  324. McClellan BL, et al. 2022. STAR Protoc. 3:101357. PubMed
  325. Governa V, et al. 2022. Proc Natl Acad Sci U S A. 119. PubMed
  326. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  327. Mai CL, et al. 2021. Theranostics. 11:1059. PubMed
  328. Chen P, et al. 2021. Clin Transl Med. 11:e462. PubMed
  329. Peng X, et al. 2021. Stem Cell Res Ther. 198:12. PubMed
  330. Linder A, et al. 2020. EMBO J. 39:e105071. PubMed
  331. Mochizuki M,et al. 2017. J Am Heart Assoc. . 10.1161/JAHA.117.005920. PubMed
  332. Roh–Johnson M, et al. 2017. Dev Cell. 43:549. PubMed
  333. Müller C, et al. 2018. Elife. 7:e34985. PubMed
  334. Guo W, et al. 2013. J Gerontol A Biol Sci Med Sci. . PubMed
  335. Liu Y, et al. 2015. Sci Rep. 5: 15134. PubMed
  336. Hodson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 2039-2046. PubMed
  337. Munson D, et al. 2016. Proc Natl Acad Sci U S A. 113: 8272 - 8277. PubMed
  338. Ubellacker J, et al. 2017. Breast Cancer Res. 10.1186/s13058-017-0815-8. PubMed
  339. DU T, et al. 2020. Front Immunol. 1.571527778. PubMed
  340. Trial J, et al. 2020. Geroscience. . PubMed
  341. Cordo' V, et al. 2022. Nat Commun. 13:1048. PubMed
  342. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  343. Denoth-Lippuner A, et al. 2021. Cell Stem Cell. 28:2020. PubMed
  344. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  345. Nagree MS, et al. 2022. EMBO Mol Med. 14:e14297. PubMed
  346. Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed
  347. Yu H, et al. 2016. Sci Rep. 6:35190. PubMed
  348. Now H, Yoo J 2016. Cell Mol Immunol. 10.1038/cmi.2016.32. PubMed
  349. Bosma M, et al. 2016. Nat Commun. 7: 11314. PubMed
  350. YC S, SJ L 2015. Sci Rep. 5: 12578. PubMed
  351. Szulzewsky F, et al. 2015. PLoS One. 10:116644. PubMed
  352. Wu C, et al. 2012. PLoS One. 7:e42363. PubMed
  353. Denning W, et al. 2011. PLoS One. 6:e16897. PubMed
  354. Weaver J, et al. 2017. Part Fibre Toxicol. 10.1186/s12989-017-0206-4. PubMed
  355. Samuelson D, et al. 2017. PLoS Pathogens. 13(6):e1006426. PubMed
  356. Wong C, et al. 2017. J Immunol. 10.4049/jimmunol.1700397. PubMed
  357. Visweshwaran SP, et al. 2022. Front Cell Dev Biol. 10:1008898. PubMed
  358. Li Q, et al. 2022. Signal Transduct Target Ther. 7:222. PubMed
  359. Fielding C, et al. 2022. Nat Commun. 13:543. PubMed
  360. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  361. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  362. Wu R, et al. 2020. J Immunother Cancer. 8:00. PubMed
  363. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  364. Roybal J, et al. 2011. Mol Cancer Res. 9:25. PubMed
  365. Cekic C, et al. 2013. J Exp Med. 210:2693. PubMed
  366. Barcia Durán JG, et al. 2021. Commun Biol. 4:406. PubMed
  367. Park HJ, et al. 2021. Int J Mol Sci. 22:. PubMed
  368. Cebrian-Silla A, et al. 2021. Elife. 10:. PubMed
  369. Yeini E, et al. 2021. Nat Commun. 12:1912. PubMed
  370. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
  371. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  372. Kucykowicz S, et al. 2022. STAR Protoc. 3:101356. PubMed
  373. Kim TW, et al. 2022. Mol Ther Oncolytics. 26:1. PubMed
  374. Kathania M, et al. 2022. Cell Rep. 40:111345. PubMed
  375. Shaashua L, et al. 2022. Nat Commun. 13:6513. PubMed
  376. Mohammed R, et al. 2016. Cell Rep. 14:760-771. PubMed
  377. Durward-Diioia M, et al. 2015. Infect Immun . 83: 4759 - 4771. PubMed
  378. Birnie K, et al. 2015. Mol Cancer Res. 13: 1106 - 1118. PubMed
  379. Liu X, et al. 2013. Invest Ophthalmol Vis Sci . 54:7386. PubMed
  380. Field-Corbett C, et al. 2009. Stem Cells. 27:662. PubMed
  381. Zeng Y, et al. 2019. FASEB J. 33:6596. PubMed
  382. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  383. Tomas C, et al. 2019. Sci Rep. 9:11464. PubMed
  384. Kim JK, et al. 2019. Bioengineering (Basel). 6:24. PubMed
  385. Alizadeh A, et al. 2018. J Neuroinflammation. 15:53. PubMed
  386. Guo P, et al. 2017. J Clin Invest. 127:4242. PubMed
  387. Tsai SC, et al. 2017. Biomicrofluidics. 11:034122. PubMed
  388. Roy IM, et al. 2021. Bio Protoc. 11:e4130. PubMed
  389. Alam A, et al. 2022. STAR Protoc. 3:101563. PubMed
  390. Xiang Y, et al. 2022. Exp Mol Med. 54:1011. PubMed
  391. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  392. Guo P, et al. 2022. Nat Cell Biol. 24:99. PubMed
  393. Wahane S, et al. 2021. Sci Adv. 7:. PubMed
  394. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  395. Huang N, et al. 2021. Nat Med. 27:892. PubMed
  396. Song X, et al. 2021. FEBS Open Bio. 11:2453. PubMed
  397. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  398. Erady C, et al. 2021. NPJ Genom Med. 6:04. PubMed
  399. de Silva S, et al. 2020. Cancer Immunol Res. 0.493055556. PubMed
  400. Wan C, et al. 2021. Cancer Res. 81:158. PubMed
  401. Wang X, et al. 2016. J Virol. 90: 10247 - 10258. PubMed

Antigen Details

Cell Type
Tregs
Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 06/10/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account